Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Ketamine Use in Conversion Disorder

Introduction to Ketamine Contradictions

  • The American College of Physicians and other medical societies suggest that ketamine has no established role in the treatment of conversion disorder and should not be used for this indication, as the available evidence is limited to treatment-resistant depression, suicidal ideation, and substance use disorders 1, 2, 3

Por qué la ketamina no es apropiada para trastorno conversivo

  • There is a total lack of evidence for ketamine's use in conversion disorder, with no studies, clinical guidelines, or case reports evaluating its use for conversive symptoms (motor or sensory) 1, 2, 3, 4, 5
  • The approved and studied indications for ketamine are completely different: treatment-resistant major depression, acute suicidal ideation in major depression, and as an anesthetic 1, 3, 5
  • Conversion disorder has a fundamentally different pathophysiology that does not involve the NMDA-glutamatergic mechanisms that ketamine modulates 2

Riesgos significativos sin beneficio potencial

  • Ketamine produces dissociative effects, hypertension, psychotomimetic symptoms, and has potential for abuse 5
  • Administering ketamine requires intensive monitoring of blood pressure, dissociative effects, and possible respiratory depression 3, 5
  • There is no long-term safety data, with concerns about urological toxicity, neurocognitive effects, and development of substance use disorder 5

REFERENCES

3

Efficacy of IV vs. Oral Ketamine for Chronic Pain and Depression [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Ketamine Therapy for Schizoaffective Disorder [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Ketamine and Esketamine for Treatment-Resistant Depression [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025